Manulife (Manufacturers Life Insurance)
SAGE

Manulife (Manufacturers Life Insurance)’s Sage Therapeutics SAGE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,880
Closed -$190K – 2984
2025
Q2 		$190K Buy
20,880
+132
+0.6% +$971 ﹤0.01% 2579
2025
Q1 		$165K Sell
20,748
-58,541
-74% -$429K ﹤0.01% 2553
2024
Q4 		$431K Sell
79,289
-75
-0.1% -$459 ﹤0.01% 2308
2024
Q3 		$573K Sell
79,364
-6,786
-8% -$62.1K ﹤0.01% 2208
2024
Q2 		$936K Sell
86,150
-5,428
-6% -$69.5K ﹤0.01% 1896
2024
Q1 		$1.72M Buy
91,578
+35,877
+64% +$828K ﹤0.01% 1573
2023
Q4 		$1.21M Sell
55,701
-308,641
-85% -$6.12M ﹤0.01% 1709
2023
Q3 		$7.5M Sell
364,342
-229,596
-39% -$6.63M ﹤0.01% 936
2023
Q2 		$27.9M Sell
593,938
-30,733
-5% -$1.53M 0.02% 494
2023
Q1 		$26.2M Sell
624,671
-462
-0.1% -$19.9K 0.01% 527
2022
Q4 		$23.9M Sell
625,133
-749
-0.1% -$28.6K 0.02% 536
2022
Q3 		$24.5M Sell
625,882
-1,046
-0.2% -$40.4K 0.02% 511
2022
Q2 		$20.3M Sell
626,928
-77,891
-11% -$2.61M 0.01% 606
2022
Q1 		$23.4M Buy
704,819
+369,595
+110% +$13.9M 0.02% 617
2021
Q4 		$14.3K Sell
335,224
-56,257
-14% -$2.36M 0.01% 787
2021
Q3 		$17.3M Buy
391,481
+105,694
+37% +$4.85M 0.01% 710
2021
Q2 		$16.2M Buy
285,787
+1,094
+0.4% +$77.3K 0.01% 766
2021
Q1 		$21.3M Buy
284,693
+26,889
+10% +$2.2M 0.02% 622
2020
Q4 		$22.3M Sell
257,804
-55,741
-18% -$4.11M 0.02% 556
2020
Q3 		$19.2M Sell
313,545
-20,373
-6% -$1.03M 0.02% 562
2020
Q2 		$13.9M Buy
333,918
+76,630
+30% +$2.78M 0.01% 650
2020
Q1 		$7.39M Buy
257,288
+5,482
+2% +$317K 0.01% 846
2019
Q4 		$18.2M Buy
251,806
+563
+0.2% +$69.3K 0.02% 588
2019
Q3 		$35.9M Sell
251,243
-3,030
-1% -$507K 0.04% 393
2019
Q2 		$46.6M Buy
254,273
+32,891
+15% +$5.61M 0.05% 318
2019
Q1 		$35.2M Hold
221,382
– – 0.04% 402
2018
Q4 		$21.2M Buy
221,382
+23
+0% +$2.63K 0.03% 505
2018
Q3 		$31.3M Buy
221,359
+69,046
+45% +$10.7M 0.03% 440
2018
Q2 		$23.8M Buy
152,313
+121,246
+390% +$19M 0.03% 536
2018
Q1 		$5M Buy
31,067
+2,370
+8% +$402K 0.01% 1226
2017
Q4 		$4.73M Buy
28,697
+2,131
+8% +$207K 0.01% 1227
2017
Q3 		$1.66M Sell
26,566
-414
-2% -$32.5K ﹤0.01% 1517
2017
Q2 		$2.15M Buy
26,980
+3,216
+14% +$232K ﹤0.01% 1426
2017
Q1 		$1.69M Buy
23,764
+3,154
+15% +$185K ﹤0.01% 1485
2016
Q4 		$1.05M Buy
20,610
+2,292
+13% +$108K ﹤0.01% 1655
2016
Q3 		$843K Sell
18,318
-43
-0.2% -$1.75K ﹤0.01% 1741
2016
Q2 		$553K Buy
18,361
+8,315
+83% +$277K ﹤0.01% 1965
2016
Q1 		$314K Buy
10,046
+489
+5% +$17.2K ﹤0.01% 2284
2015
Q4 		$557 Buy
9,557
+103
+1% +$5.1K ﹤0.01% 1957
2015
Q3 		$400 Buy
9,454
+214
+2% +$13.2K ﹤0.01% 2142
2015
Q2 		$674 Buy
9,240
+4,740
+105% +$305K ﹤0.01% 1921
2015
Q1 		$226 Buy
4,500
+128
+3% +$5.5K ﹤0.01% 2642
2014
Q4 		$160 Buy
+4,372
New +$163K ﹤0.01% 2806

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s SAGE Position: Q3 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 20,880 shares — an estimated $190K sold.

Manulife (Manufacturers Life Insurance) first reported a position in SAGE in Q4 2014 and held it in 43 quarters. The position peaked at $46.6M in Q2 2019. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 20,880 Sage Therapeutics shares in Q3 2025, an estimated $190K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Sage Therapeutics in Q4 2014 and held it in 43 quarters.
  • Manulife (Manufacturers Life Insurance)'s Sage Therapeutics position peaked at $46.6M in Q2 2019.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2025, filed 14 Nov 2025.